All Activity

The web is actually bogged lower along with phony weblogs without any actual information however the publish had been wonderful as well as really worth the actual study. Thanks with regard to discussing this particular beside me. sbobet

Yes, I am entirely agreed with this article, and I just want say that this article is very helpful and enlightening. I also have some precious piece of concerned info !!!!!!Thanks. situs slot resmi

This particular is usually apparently essential and moreover outstanding truth along with for sure fair-minded and moreover admittedly useful My business is looking to find in advance designed for this specific useful stuffs… วิธีแทงบอลสเต็ปสำหรับมือใหม่

Wow i can say that this is another great article as expected of this blog.Bookmarked this site.. kokitoto daftar

Thank you for very usefull information.. game premium oma55

The best horror survival game ever made is FNAF; how about we play it? Discover the terrifying Five Nights at Freddy's with its unsettling shifts and face-moving animatronics right now!

You can drift in Drift Boss for a long time, and the game tests your speed and ability to drive through difficult tracks. Everyone can enjoy the game. You can try to beat your high score, get coins, or open up new cars. There is something new to learn every time you play.

If you want to dive into a brilliant galaxy of quick actions and great smiles, Space Waves is a game that you can play online for free. Maintain a straight line while guiding a bright arrow through neon tunnels using a control that is simple and only requires one button. Every single run is quick, fair, and enjoyable thanks to the game's 33 colourful stages and immediate restarts. Is you prepared to surf the wave?

“The question of whether to create a psilocybin therapeutic access program is not about if, but how it will be implemented.” By Jessica Nielson, Minnesota Psychedelic Medicine Task Force via Minnesota Reformer The Minnesota Legislature in 2023 created the Psychedelic Medicine Task Force, which was charged with evaluating whether we should expand access to psychedelic medicines here to help address the rampant mental health crisis. The backdrop: Promising therapies like psilocybin-assisted treatments for depression, addiction and trauma are gaining traction towards approval by the Food and Drug Administration, and other states like Oregon and Colorado have already legalized therapeutic access. Wait, what are psychedelics you might ask? They are a class of drugs made illegal (Schedule I status) in 1970 with the birth of the Controlled Substances Act by the Nixon administration. In the 1950s through about 1970, they were gaining traction at psychiatric clinics, where they were being used to treat mental health conditions and alcohol abuse. At the same time, the hippies were also using them as part of the countercultural movement that was protesting the Vietnam War and supporting the Civil Rights Movement. The Controlled Substances Act effectively launched the War on Drugs and halted progress on promising research into the therapeutic potential of psychedelics—like so-called magic mushrooms aka psilocybin—for decades, and made all those who use them criminals. In recent years, however, there has been a surge of interest in psychedelic medicines for their potential to change the way the brain functions, potentially alleviating some of the most difficult-to-treat mental health conditions that are byproducts of neurological patterns that get stuck in a pathological cycle. Psychedelics are able to make the brain more capable of changing, a term called neuroplasticity, which has a lot of researchers and clinicians excited about their therapeutic applications for neurological and mental health disorders. Fast forward to 2026, when President Donald Trump signed an executive order to accelerate access to psychedelic medicines. It also included a section directing federal agencies to develop a framework for state-federal collaboration, which was a response to the surge of psychedelic-focused legislation we’ve seen around the country in recent years. All of this recent momentum made for a very productive legislative session on psychedelics. Several bills moved through the Legislature, though we came up short of our ultimate goal, which was to create a therapeutic access program with psilocybin mushrooms. We did manage to get passed a directive to the Office of Cannabis Management to implement a feasibility study and legislative report due January 15, 2027. The report will outline a framework to implement a therapeutic psilocybin program with patients who have undergone screening and have a qualifying health condition. Over the coming months, the Office of Cannabis Management will be working on their report about what the regulatory landscape will look like to develop and implement a state-regulated therapeutic psilocybin program. Thanks to the leaders who participated in the Psychedelic Medicine Task Force, Minnesota already has a 200-page guidebook for legal, regulatory, scientific, cultural and ethical considerations for integrating psychedelic medicines into our society. It’s the result of 14 months of work by 23 members, and it can also serve as a national resource to help all states develop policies and programs related to this important work. The point being: the Office of Cannabis Management does not have to start from scratch. It already has the report, the policy framework advanced by the House, testimony from patients, veterans, clinicians and families—and a clear signal that there is broad interest in getting this right. The question of whether to create a psilocybin therapeutic access program is not about if, but how it will be implemented. We demonstrated this session that there is broad bipartisan support at the local, state and federal levels. Many states are considering legislation to determine how their state will address integrating psychedelic medicines into their systems of care, and Minnesota has an opportunity to be a leader and pioneer in this effort. With so much promising research and support for psychedelic medicines, we should view what passed this session as a planning phase for action in 2027, for the Legislature to pass this access program and help Minnesotans heal from some of the most difficult-to-treat mental health conditions impacting so many of our friends and family. Jessica Nielson, PhD, is chair of the Minnesota Psychedelic Medicine Task Force. She’s an adjunct assistant professor, in the Department of Psychiatry and Behavioral Sciences, University of Minnesota. She’s also founder and president, Psychedelic Society of Minnesota. This piece was first published by Minnesota Reformer. Photo courtesy of Mark Groeneveld. The post Minnesota Is On The Cusp Of Making Psychedelic Medicine Available (Op-Ed) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Great job for publishing such a beneficial web site. Your web log isn’t only useful but it is additionally really creative too. slot 5000

This is such a great resource that you are providing and you give it away for free. I love seeing blog that understand the value of providing a quality resource for free. ufa88s

Pretty good post. I just stumbled upon your blog and wanted to say that I have really enjoyed reading your blog posts. Any way I'll be subscribing to your feed and I hope you post again soon. Big thanks for the useful info. ombak700

“Our current presumption has the practical effect of stripping those who use marijuana…of their Fourth Amendment right against unreasonable search and seizure.” By Carolina Journal The newest member of the 4th US Circuit Court of Appeals used a North Carolina case Wednesday to discuss the potential legal impact of shifting attitudes about marijuana. Judge Nicole Berner offered her commentary in an eight-page concurring opinion in United States v. Carson. Then-President Joe Biden appointed Berner to the 4th Circuit in 2024. Appellate judges upheld Jermaine Derrick Carson Jr.’s conviction on a federal charge of firearm possession by a felon. The court rejected Carson’s arguments that evidence against him should have been suppressed. That included evidence resulting from Asheville police detective Steven Escobedo frisking Carson during a traffic stop. Berner supported most of the majority decision. Yet she dedicated much of her concurrence to the link between marijuana and law enforcement searches. “I agree with my colleagues that our precedent in United States v. Sakyi dictates the outcome of this case,” Berner wrote, citing a 1998 4th Circuit precedent. “Sakyi created a presumption that a police officer has reasonable suspicion to frisk a suspect for a weapon during a traffic stop when he reasonably suspects that there are illegal drugs in the car,” Berner explained. “Applying this binding precedent, we are left with no choice but to conclude that Escobedo frisking Carson for weapons did not violate Carson’s Fourth Amendment rights because Escobedo reasonably suspected that there was marijuana in the car.” “The Sakyi presumption rests on a simple premise: ‘where there are drugs, there are almost always guns,’” Berner wrote. “This premise—that an individual who is suspected of being in proximity to illicit drugs is likely carrying a gun—can no longer hold water in this era of widespread marijuana legalization.” “In the nearly thirty years since Sakyi was decided, the purported nexus between marijuana use and gun possession has become attenuated,” she added. “Indeed, the Government conceded as much at oral argument.” “The legal landscape around marijuana use, both medical and recreational, has shifted considerably both at the state and federal level,” Berner continued. “Forty-seven states and the District of Columbia now allow the use of marijuana for medical purposes. Twenty-four states, including a number within the Fourth Circuit itself, have legalized recreational marijuana use. Though federal law continues to criminalize marijuana, the federal government ‘has largely tolerated the production and sale of marijuana when done in accord with state law, and it has allowed a multi-billion-dollar marijuana business to develop.’” “Sakyi relies on an assumption that individuals using and dealing illicit drugs are likely to be carrying guns for protection while engaged in illegal drug transactions,” Berner argued. “Against the backdrop of changes in federal law and widespread state legalization, such safety concerns are now notably absent for many marijuana users. An individual in Maryland, for example, can walk into a dispensary and legally purchase marijuana with no need for the type of protection upon which Sakyi based its nexus analysis.” Berner highlighted the actions of Asheville police in Carson’s case. “The facts of this case demonstrate this unassailable attenuation between marijuana use and dangerousness,” the judge wrote. “The officers themselves repeatedly assured Carson and the other occupants of the car that they were ‘not the weed police.’ Indeed, even though marijuana remains unlawful in North Carolina, the Asheville Police Department no longer charges individuals who possess personal use amounts of marijuana. This approach follows the lead of the Department of Justice which directed federal prosecutors to forgo marijuana prosecutions over a decade ago.” Government prosecutors are now “in the ‘awkward’ position of suggesting that ‘millions of Americans who now regularly use marijuana are categorically and unusually dangerous,’” Berner wrote. “The Supreme Court’s recent decision in United States v. Hemani underscores the need to revisit our presumption. There, the Court held unconstitutional a statute criminalizing firearm possession as applied to occasional marijuana users.” “The Court explicitly rejected that a link between dangerousness and marijuana use could be sustained in view of the evolving legal and social landscape,” the concurrence continued. “Yet, under the law of our circuit, reasonable suspicion to frisk for weapons continues to be presumed anytime a police officer even so much as detects the smell of marijuana.” The 4th Circuit’s “approach stands in contrast to decisions from our sister circuits,” Berner argued. A single three-judge 4th Circuit panel could not change that approach. “Accordingly, we are bound by Sakyi, and I join my colleagues in their carefully reasoned opinion,” Berner wrote. “I write separately to underscore that our current presumption has the practical effect of stripping those who use marijuana, even in states where it has been legalized under state law, and even individuals who simply find themselves in near proximity to others using marijuana, of their Fourth Amendment right against unreasonable search and seizure.” “As laws and social mores regarding marijuana continue to evolve, this presumption may no longer survive constitutional scrutiny,” Berner added. This story was first published by Carolina Journal. Photo elements courtesy of rawpixel and Philip Steffan. The post Federal Judge Questions Link Between Marijuana And Guns, Citing ‘Widespread State Legalization’ appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Literally Document look at the software yesterday evening still I had produced a lot of emotions relating to this now I needed to read the software once as it is relatively well crafted. slot online

Very efficiently written information. It will be beneficial to anybody who utilizes it, including me. Keep up the good work. For sure i will check out more posts. This site seems to get a good amount of visitors. slot deposit 5k

You have a great sense of writing I must say. Your post has those facts which are not accessible from anywhere else. It’s my humble request to u please keep writing such remarkable articles mega.nz files

The website is looking bit flashy and it catches the visitors eyes. Design is pretty simple and a good user friendly interface. kokitoto

Nice blog and absolutely outstanding. You can do something much better but i still say this perfect.Keep trying for the best. 가상계좌 솔루션

Very efficiently written information. It will be beneficial to anybody who utilizes it, including me. Keep up the good work. For sure i will check out more posts. This site seems to get a good amount of visitors. bandar slot online

This is such a great resource that you are providing and you give it away for free. I love seeing blog that understand the value. Im glad to have found this post as its such an interesting one! I am always on the lookout for quality posts and articles so i suppose im lucky to have found this! I hope you will be adding more in the future... 가상계좌 솔루션

Very efficiently written information. It will be beneficial to anybody who utilizes it, including me. Keep up the good work. For sure i will check out more posts. This site seems to get a good amount of visitors. buastoto

Meeting someone new can feel daunting, but we've removed that discomfort. High Profile Escort Delhi makes first encounters feel completely natural and relaxed. Her friendly approach and genuine interest in you create an environment where you can be yourself. Clients often say they felt comfortable within minutes rather than hours.

People with restless legs syndrome (RLS) could find “significant” long-term relief with cannabis treatment, according to a new study. Researchers said that while dopamine agonists have traditionally served as the “first-line treatment” of RLS, recent studies have signaled that gabapentinoids are now being recommended. Because cannabinoids, like gabapentinoids, inhibit a certain type of amino acid associated with the disorder, the scientists decided to test their therapeutic efficacy. The exploratory open-label study, conducted by researchers at Universidad Europea de Madrid and published in the Journal of Neurology, found that a cannabis product containing 2.7mg THC and 2.5mg CBD “was effective in reducing RLS severity” among patients with multiple sclerosis and “associated idiopathic RLS.” “Improvements were observed after 1 and 3 months of treatment and were maintained after 1 year among patients who continued therapy,” the study of 18 patients with RLS showed. For those that remained on treatment after one year, 67 percent “continued to show sustained improvement.” The findings might not be especially surprising given that cannabis is well-known to reduce the severity of muscular spasms and related conditions, but its efficacy for RLS is notable considering that no states appear to explicitly list it as a qualifying condition for medical cannabis. Of course, RLS may be a symptom of other overarching disorders such as multiple sclerosis—and certain states give doctors wider latitude to make medical marijuana recommendations for any condition that they see fit. In any case, the study out of Spain could build upon emerging research into alternative treatment options that could replace dopamine agonists in the treatment of restless legs syndrome. The post Medical Marijuana Is ‘Effective’ In Providing Relief To Patients With Restless Legs Syndrome, Study Shows appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

The former head of the Department of Homeland Security under the first Trump administration is warning lawmakers against keeping hemp THC products legal, claiming that reversing a ban that is set to take effect later this year would “undermine public health” and “embolden foreign criminal actors.” Chad Wolf, who served as acting secretary of homeland security from late 2019 to early 2021, sent a letter urging leaders of the House Select Committee on the Strategic Competition between the United States and the Chinese Communist Party to investigate the “growing role that Chinese-linked actors and foreign criminal organizations are playing in the proliferation of hemp-derived tetrahydrocannabinol (THC) products and illegal marijuana operations” in the U.S., saying they are “putting our youth and adults at risk.” “What began as a narrowly tailored effort to legalize industrial hemp and non-intoxicating cannabidiol (CBD) products has evolved into a dangerous and unregulated market for high-potency THC hemp products that are being sold across the country with little to no oversight,” the letter says. “These products are frequently marketed as gummies, candies, beverages and vapes, often packaged and promoted in ways that appeal to children. They lack acceptable age restrictions, labeling requirements and safety standards.” Hemp derivatives with less than 0.3 percent delta-9 THC on a dry-weight basis were federally legalized under the 2018 Farm Bill that President Donald Trump signed during his first term in office. But late last year, he signed new legislation containing provisions that will redefine hemp to make it so only products with 0.4 milligrams of total THC per container will remain legal after November 12. In recent weeks, however, the White House and lawmakers from both parties have been pushing congressional leadership to delay, alter or reverse the ban. In a letter to House Speaker Mike Johnson (R-LA) last month, White House Office of Management and Budget (OMB) Director Russell Vought said the administration wants lawmakers to “ensure the fair treatment of hemp products”—specifically citing legislation that would keep many hemp products legal that are currently set to be recriminalized this year, add labeling requirements and institute new taxes on sales, among other regulatory reforms. But Wolf argues that would be a mistake. “Congress acted last year, with bipartisan support and President Trump’s signature, to close loopholes involving intoxicating THC hemp products and restore the original intent of federal hemp legislation,” he wrote in the letter, which was first reported by Fox News. “However, efforts are now underway to weaken, delay or roll back those protections before they fully take effect. This would not only undermine public health and law enforcement objectives, but could further embolden foreign criminal actors seeking to exploit the American marketplace and harm American families.” “Beyond the serious public health implications, there is mounting evidence that this issue also presents a significant national security concern,” the former acting homeland security secretary wrote to Reps. John Moolenaar (R-MI) and Ro Khanna (D-CA), who are, respectively, the chair and tanking member of the China-focused committee. Intoxicating THC hemp products linked to China are flooding American markets – targeting children, fueling transnational crime, and raising serious national security concerns. Congress should act quickly to protect the American people from these threats. See more from @FoxNews:… — Chad Wolf (@ChadFWolf) July 9, 2026 Wolf, whose appointment as acting homeland security secretary was ruled unlawful by a federal court and now serves as executive director for the America First Policy Institute, said that China “has been linked to the export of fentanyl, synthetic narcotics and illicit supply chain materials that have devastated American communities,” adding that “the intoxicating THC hemp market now risks becoming another avenue through which Chinese-linked actors exploit regulatory loopholes and weak enforcement mechanisms to profit at the expense of the health and safety of the American people.” He is asking the House panel to “investigate China’s involvement in the intoxicating THC hemp supply chain, including financing, chemical manufacturing, illegal cultivation operations, money laundering activity and ties to the array of criminal organizations operating within the United States.” The Trump administration, meanwhile, “welcomes the opportunity to work with the Congress to, at a minimum, update the statutory definition of final hemp-derived cannabinoid products to allow Americans to benefit from access to appropriate full-spectrum CBD products,” OMB separately said last month, “while preserving the Congress’s intent to restrict the sale of products that pose serious health risks.” The call to avert a broad prohibition on hemp CBD products was included in a statement of administration policy about an annual agriculture spending bill that passed the House of Representatives. Several lawmakers had filed amendments to that legislation to keep hemp products legal, but each was either blocked by the House Rules Committee from advancing to a floor vote or withdrawn by its sponsor. “The Administration supports advancement of this legislation, but looks forward to addressing its concerns prior to enactment,” OMB said in its statement of administration policy. “The Administration looks forward to working with the Congress to provide more input as the bill’s legislative process unfolds.” In April, the president himself urged congressional lawmakers to again redefine hemp to avoid recriminalization of full-spectrum CBD products. “I am calling on Congress to update the Law to ensure that Americans can continue to access the full-spectrum CBD products they have come to rely on, and that help them, while preserving Congress’s intent to restrict the sale of products that pose Health risks,” Trump said in a Truth Social post on the same day his administration announced it is moving forward with rescheduling marijuana. “We must get this done RIGHT and FAST, especially for those who saw that CBD helps them,” he said. “Plus, I am told it will also help our GREAT FARMERS, who we love, and will always be there for.” Industry advocates say that the law as enacted last year not only threatens to prohibit intoxicating and synthetic cannabinoid products but also stands to remove popular full-spectrum CBD products that many Americans use therapeutically from the market. “ONE in FIVE adults used it in the past year, and many say it improved their chronic pain enormously,” the president said in his social media post, adding that hemp-derived CBD “has made a HUGE difference for so many people.” He also referenced a new initiative the administration launched in April to cover up to $500 worth of hemp-derived products each year for eligible Medicare patients. The program being implemented by the Centers for Medicare & Medicaid Services (CMS) focuses largely on CBD but also allows products to have up to 3 milligrams of total THC per serving. “In December, I signed a very important Executive Order calling for Research and Innovation for Hemp-derived CBD,” Trump said. “Our wonderful Dr. Mehmet Oz moved fast to follow the directive in the Executive Order, and launched a model for some Seniors earlier this month. But more must be done!” “Please get it done, and SOON,” the president said in reference to a congressional fix for the broad recriminalization set to take effect in November. “Thank you for your attention to this matter!” It’s not clear how far Trump wants to scale back the scope of the scheduled federal restrictions on hemp products and what kinds of revised THC rules and limitations he would prefer to sign into law. As Marijuana Moment reported last month, a Republican congresswoman is circulating draft legislation that would keep hemp THC beverages legal under federal law, creating a carve-out from the broad recriminalization of products derived from the crop that is set to take effect later this year. The Hemp-Derived Beverage Regulatory Clarity Act from Rep. Beth Van Duyne (R-TX), in its current form, would allow adults over 21 to purchase and consume hemp THC drinks with up to 5 milligrams of delta-9 THC per serving. It would also impose a federal tax of 10 cents per milligram of any hemp-derived cannabinoid contained within such beverages. The National Restaurant Association, which represents the industry, recently sent a letter urging congressional leaders to delay the federal recriminalization of hemp THC beverages that is scheduled to take effect later this year and replace it with a regulatory framework that “ensures consumer safety while meeting growing market demand” for the products as an alternative to alcohol. A U.S. Department of Agriculture report published in April shows that farmers in the U.S. grew three-quarters of a billion dollars worth of hemp crops in 2025—a 64 percent increase from the prior year. The post Former Trump Homeland Security Official Pushes Congress To Keep Hemp THC Product Ban On Track, Warning Of Chinese Threat appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A Republican congressman claims that using marijuana “hurts your DNA,” will “make you a loser in life” and leads to young women being “taken advantage of.” Rep. Pete Sessions (R-TX), one of the most outspoken opponents of cannabis legalization in Congress, made the comments in an appearance on “High Stakes,” a podcast produced by the prohibitionist organization Smart Approaches to Marijuana (SAM). “If you want to become a loser in life—if you want, as a young woman, to be around areas where the knowledge that you have of being assaulted, taken advantage of, and harming your life—just go forth and be around marijuana,” he said. “I became very aware in college about people who used marijuana, who ended up literally dropping out—dropping out of life—who just chose that way of life,” he said. “I saw it from a personal perspective of a danger to someone’s future in their life.” “There is not one positive effect of this marijuana,” Sessions claimed, despite the fact that nearly every state in the country has legalized cannabis for medical uses and the Trump administration has partially federally rescheduled it, officially recognizing its therapeutic value. The GOP lawmaker also spoke about how his father, former FBI Director William Sessions, was responsible for putting a warning that “Winners Don’t Use Drugs” on numerous arcade games. “Yeah, it says right under there, William S. Sessions, director of the FBI,” the congressman said. “If you want to be a loser in life, feel free to mess around with marijuana.” Cannabis “integrates itself to destroy your ability to effectively grow your mind, your brain and your body, and it correspondingly hurts your DNA and beyond,” Sessions claimed. “And the facts of the case are very open and very well known, of the psychosis through addiction that it creates. It has created losers all across every single state that has legalized marijuana.” “But the people who go and vote for these things as they did in Colorado, felt like they would make money off people’s misery—and in fact the amount of money in Colorado that was supposed to then be to help other state functions never materialized because nobody wants to pay taxes and so it has just encouraged the illegal selling of marijuana. And yet we still have huge numbers of people that are showing up at their hospitals, at their emergency room psychosis, the devastating effect that takes place.” The lawmaker went on to claim that cannabis is a “starter drug” to use of other substances. “I will continue to encourage those in public policy, including the administration, to understand the terrible cost that is happening on the American society and out future,” he said. “And you can see it most plainly when you look at all of the heroin and cocaine that flows into this country.” Sessions, who called cannabis a “catalyst for deaths on the highway” in the new interview, recently appeared at a press conference with an organization that represents the drug testing industry and pushed for the Department of Transportation to keep testing safety-sensitive workers for marijuana even in light of federal rescheduling. While serving as chairman of the House Rules Committee, Sessions played a key role in blocking dozens of cannabis- and drug policy-related amendments from advancing to floor votes. The post Using Marijuana Will Make You ‘A Loser In Life,’ GOP Congressman Says appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net